6.83
3.17%
0.21
Handel nachbörslich:
6.85
0.02
+0.29%
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
26.39%
10.85
|
8.587 | 8.52 | 13.26 | 7.145 |
Operating Income/Loss |
26.37%
-10.85
|
-8.588 | -8.52 | -13.26 | -7.145 |
Nonoperating Income/Loss |
77.26%
0.876
|
3.853 | 1.464 | 4.587 | 3.292 |
Income/Loss From Continuing Operations Before Tax |
115.25%
-9.977
|
-4.635 | -7.056 | -8.671 | -3.853 |
Income Tax Expense/Benefit |
125.25%
0.025
|
-0.099 | 0.308 | 0.071 | -0.037 |
Income/Loss From Continuing Operations After Tax |
115.79%
-10.00
|
-4.635 | -7.364 | -8.742 | -3.816 |
Net Income/Loss
|
115.79%
-10.00
|
-4.635 | -7.364 | -8.742 | -3.816 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2.15M%
30.44
|
0.00142 | 30.44 | 30.44 | 30.44 |
Basic Earnings Per Share |
120.00%
-0.33
|
-0.15 | -0.24 | -0.29 | -0.13 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):